Campbell Newman Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-2,519
Closed -$424K 132
2018
Q1
$424K Buy
2,519
+21
+0.8% +$3.52K 0.07% 107
2017
Q4
$409K Sell
2,498
-20
-0.8% -$3.59K 0.07% 103
2017
Q3
$516K Buy
2,518
+37
+1% +$8.61K 0.09% 81
2017
Q2
$603K Sell
2,481
-16
-0.6% -$3.76K 0.11% 77
2017
Q1
$597K Sell
2,497
-21
-0.8% -$4.89K 0.11% 75
2016
Q4
$529K Sell
2,518
-1,658
-40% -$343K 0.1% 78
2016
Q3
$962K Sell
4,176
-195
-4% -$47.7K 0.17% 61
2016
Q2
$1.01M Sell
4,371
-698
-14% -$161K 0.18% 63
2016
Q1
$1.36M Buy
5,069
+11
+0.2% +$3.15K 0.28% 43
2015
Q4
$1.58M Sell
5,058
-148
-3% -$44.1K 0.34% 41
2015
Q3
$1.42M Sell
5,206
-37
-0.7% -$11.4K 0.32% 42
2015
Q2
$1.59M Sell
5,243
-16
-0.3% -$4.77K 0.32% 40
2015
Q1
$1.56M Buy
5,259
+3,459
+192% +$986K 0.29% 42
2014
Q4
$463K Buy
+1,800
New +$450K 0.09% 75

Other funds holding AGN

Campbell Newman Asset Management's AGN Position: Q2 2018 in Review

Campbell Newman Asset Management sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 2,519 shares — an estimated $424K sold.

Campbell Newman Asset Management first reported a position in AGN in Q4 2014 and held it in 14 quarters. The position peaked at $1.59M in Q2 2015. 1,044 funds tracked by Wall St. Rank hold AGN as of Q2 2018.

  • Campbell Newman Asset Management reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
  • Campbell Newman Asset Management sold 2,519 Allergan plc shares in Q2 2018, an estimated $424K.
  • Campbell Newman Asset Management first reported a position in Allergan plc in Q4 2014 and held it in 14 quarters.
  • Campbell Newman Asset Management's Allergan plc position peaked at $1.59M in Q2 2015.
  • 1,044 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.

Based on Campbell Newman Asset Management's 13F filing for Q2 2018, filed 25 Jul 2018.